Adaptive designs in clinical trials
In addition to the expensive and lengthy process of developing a new medicine, the attrition rate in clinical research was on the rise, resulting in stagnation in the development of new compounds. As a consequence to this, the US Food and Drug Administration released a critical path initiative docum...
Main Author: | Suresh Bowalekar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Perspectives in Clinical Research |
Subjects: | |
Online Access: | http://www.picronline.org/article.asp?issn=2229-3485;year=2011;volume=2;issue=1;spage=23;epage=27;aulast=Bowalekar |
Similar Items
-
Adaptive designs in critical care trials: a simulation study
by: W. Li, et al.
Published: (2023-10-01) -
Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN
by: Alexandra R. Brown, et al.
Published: (2023-12-01) -
Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
by: Nick R. Parsons, et al.
Published: (2022-10-01) -
Trial sequential analysis: novel approach for meta-analysis
by: Hyun Kang
Published: (2021-04-01) -
Group Sequential Designs Applied in Psychological Research
by: Klemens Weigl, et al.
Published: (2020-04-01)